Solid Biosciences Inc. — Investor Relations & Filings

Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates. The company develops treatments for rare and devastating neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich’s ataxia, catecholaminergic polymorphic ventricular tachycardia (CPVT), and various forms of dilated cardiomyopathy. In addition to its therapeutic pipeline, Solid Biosciences develops enabling technologies, such as innovative libraries of genetic regulators, to improve gene therapy delivery. The company's mission is to improve the lives of patients by uniting experts in science, technology, and disease management.